Upton, Coburn Seek More Information on Non-Tamper-Resistant Prescription Drugs Set to Hit Market
Drugs Like Oxycontin Currently Manufactured with Tamper Resistant Formulas – Law Enforcement, Health Care Officials, and Parents Concerned with the Prospect of Non-Tamper-Resistant Versions Hitting the Market, Making Powerful Prescription Drugs Easier to Crush and Abuse
WASHINGTON, DC – Energy and Commerce Committee Chairman Fred Upton (R-MI) and Senator Tom Coburn (R-OK) today requested the Department of Health and Human Services provide more information on its efforts to address the growing concerns surrounding the imminent release of non-tamper-resistant versions of extended-release opioids, such as Oxycontin.
The members wrote, "During...
Letter to HHS Regarding Non-Tamper-Resistant Prescription Drugs
Excerpt: During the past month, we have heard from a number of concerned citizens, including parents, law enforcement officials, health care providers, state and local officials, and our colleagues in Congress, about the impending release of the non-tamper-resistant versions of these opioids. According to these concerned citizens, the release of the non-tamper-resistant versions will deal a significant setback to our nation’s ongoing struggle to stop prescription drug abuse.
To read the letter, click here.
To read a related press release, click here.